These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11366083)

  • 1. Simply stated...absorbing reading.
    Res Initiat Treat Action; 1998 Dec; 4(7):19. PubMed ID: 11366083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing regimens: what's it all about, Alfie?
    Res Initiat Treat Action; 1998 Feb; 4(1):15. PubMed ID: 11365216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking anti-HIV drugs.
    Fornataro K; Jefferys R
    Body Posit; 1999 Apr; 12(4):32-5. PubMed ID: 11366273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Guide 2000: the antiretroviral agents.
    Gallant JE
    Posit Aware; 2000; 11(1):30-1. PubMed ID: 11366347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycles, anti-HIV drugs and treatment.
    Proj Inf Perspect; 2003 Jan; (35):18-9. PubMed ID: 12647679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient adherence to prescribed antimicrobial drug dosing regimens.
    Vrijens B; Urquhart J
    J Antimicrob Chemother; 2005 May; 55(5):616-27. PubMed ID: 15772145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplifying antiretroviral therapy.
    Tapper ML; Flexner C; Eron JJ; Molina JM
    AIDS Read; 2004 Jul; 14(7):355-60, 367-71. PubMed ID: 15282865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplifying drug regimens goal of research.
    Gaylord G
    Posit Living; 1999 Nov; 8(10):6, 56. PubMed ID: 11367337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staying on schedule.
    Price J
    STEP Perspect; 1999; 99(1):13-4. PubMed ID: 11367155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-drug interactions that matter.
    Back DJ
    Top HIV Med; 2006; 14(2):88-92. PubMed ID: 16835464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making the most of once-daily anti-HIV therapy.
    Cox S
    Posit Aware; 1998; 9(6):43. PubMed ID: 11366482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interactions of antiretroviral drugs].
    Fuertes A; Otero MJ
    Med Clin (Barc); 1999 Jun; 113(3):94-102. PubMed ID: 10464744
    [No Abstract]   [Full Text] [Related]  

  • 14. Daily dosing of highly active antiretroviral therapy.
    Rosenbach KA; Allison R; Nadler JP
    Clin Infect Dis; 2002 Mar; 34(5):686-92. PubMed ID: 11823957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of once- and twice-daily dosing regimens on adherence and overall safety.
    Hawkins T
    AIDS Read; 2004 Jun; 14(6):320-2, 324, 329-31, 334-6. PubMed ID: 15243968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily dosing of nevirapine in HAART.
    Clotet B
    J Antimicrob Chemother; 2008 Jan; 61(1):13-6. PubMed ID: 18006524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily therapy: less is more.
    Moyle G
    Int J STD AIDS; 2003 Oct; 14 Suppl 1():1-5. PubMed ID: 14617397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class-sparing treatment therapies.
    Proj Inf Perspect; 1999 Apr; (27):5-6. PubMed ID: 11366740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of once a day HIV treatment.
    Pozniak AL
    J HIV Ther; 2004 Nov; 9(4):73-4. PubMed ID: 15731737
    [No Abstract]   [Full Text] [Related]  

  • 20. How much does it really matter if you take your pills on time?
    Mirken B
    BETA; 1997 Sep; ():9-13, 16. PubMed ID: 11364710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.